These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Galectin-2 3279TT variant protects against the lymphotoxin-alpha 252GG genotype associated ischaemic stroke. Szolnoki Z, Maasz A, Magyari L, Horvatovich K, Farago B, Kondacs A, Bodor A, Hadarits F, Orosz P, Ille A, Melegh B. Clin Neurol Neurosurg; 2009 Apr; 111(3):227-30. PubMed ID: 19013708 [Abstract] [Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women. Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D, Rimm EB. Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1654-8. PubMed ID: 15920035 [Abstract] [Full Text] [Related]
6. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D, Rimm EB. Obesity (Silver Spring); 2007 Aug; 15(8):2051-60. PubMed ID: 17712123 [Abstract] [Full Text] [Related]
7. Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Jukema JW, PROSPER Group. Exp Gerontol; 2008 Aug; 43(8):801-5. PubMed ID: 18504081 [Abstract] [Full Text] [Related]
8. Lack of association between lymphotoxin-alpha, galectin-2 polymorphisms and coronary artery disease: a meta-analysis. Li W, Xu J, Wang X, Chen J, Zhang C, Sun K, Hui R. Atherosclerosis; 2010 Feb; 208(2):433-6. PubMed ID: 19726041 [Abstract] [Full Text] [Related]
10. Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. Pai JK, Manson JE, Rexrode KM, Albert CM, Hunter DJ, Rimm EB. Eur Heart J; 2007 Jun; 28(11):1297-303. PubMed ID: 17483111 [Abstract] [Full Text] [Related]
13. Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Laxton R, Pearce E, Kyriakou T, Ye S. Genes Immun; 2005 Sep; 6(6):539-41. PubMed ID: 15973460 [Abstract] [Full Text] [Related]
14. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Morange PE, Tiret L, Saut N, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Cambien F, Juhan-Vague I, PRIME Study Group. Eur J Hum Genet; 2004 Dec; 12(12):1041-9. PubMed ID: 15367917 [Abstract] [Full Text] [Related]
16. An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene. Nakayama T, Soma M, Sato N, Haketa A, Kosuge K, Aoi N, Sato M, Izumi Y, Matsumoto K, Kanmatsuse K, Kokubun S. Am J Hypertens; 2004 Nov; 17(11 Pt 1):1045-9. PubMed ID: 15533732 [Abstract] [Full Text] [Related]
19. Association between a polymorphism in the lymphotoxin-a promoter region and migraine. Lee KA, Jang SY, Sohn KM, Won HH, Kim MJ, Kim JW, Chung CS. Headache; 2007 Nov; 47(7):1056-62. PubMed ID: 17635597 [Abstract] [Full Text] [Related]
20. Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis. Panoulas VF, Nikas SN, Smith JP, Douglas KM, Nightingale P, Milionis HJ, Treharne GJ, Toms TE, Kita MD, Kitas GD. Ann Rheum Dis; 2008 Nov; 67(11):1550-6. PubMed ID: 18230628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]